SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+34.67%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$555M
AUM Growth
+$555M
(+54%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
19.36%
Top 10 Holdings %
Top 10 Hldgs %
64.54%
Holding
91
New
25
Increased
22
Reduced
13
Closed
17
Top Buys
| 1 |
THER
THERATECHNOLOGIES INC COM
THER
|
$26.9M |
| 2 |
Krystal Biotech
KRYS
|
$12.1M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11M |
| 4 |
AstraZeneca
AZN
|
$9.65M |
| 5 |
C4 Therapeutics
CCCC
|
$7.23M |
Top Sells
| 1 |
NVTA
Invitae Corporation
NVTA
|
$10.2M |
| 2 |
ESSA Pharma
EPIX
|
$8.88M |
| 3 |
Vericel Corp
VCEL
|
$7.31M |
| 4 |
Mersana Therapeutics
MRSN
|
$5.5M |
| 5 |
Exelixis
EXEL
|
$4.71M |
Sector Composition
| 1 | Healthcare | 90.73% |
| 2 | Consumer Staples | 1.79% |
| 3 | Real Estate | 0.62% |
| 4 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
26
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.87M | 0.7% | 25,318 +6,380 | +34% | +$975K |
|
27
Establishment Labs
ESTA
$1.2B
| $3.82M | 0.69% | 61,151 -5,770 | -9% | -$361K |
|
28
4D Molecular Therapeutics
FDMT
$288M
| $3.74M | 0.67% | +86,100 | New | +$3.74M |
|
|
CUTR
29
DELISTED
Cutera, Inc.
CUTR
| $3.61M | 0.65% | +120,000 | New | +$3.61M |
|
30
Philips
PHG
$26.2B
| $3.48M | 0.63% | +61,050 | New | +$3.48M |
|
31
DarioHealth
DRIO
$22.8M
| $3.44M | 0.62% | 178,814 -222,792 | -55% | -$4.29M |
|
32
Rafael Holdings
RFL
$51.6M
| $3.42M | 0.62% | 85,637 -19,100 | -18% | -$763K |
|
|
KNTE
33
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.4M | 0.61% | +109,000 | New | +$3.4M |
|
34
NovoCure
NVCR
$1.38B
| $3.35M | 0.6% | 25,325 +326 | +1% | +$43.1K |
|
|
ALPN
35
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $3.32M | 0.6% | 313,064 +272,000 | +662% | +$2.88M |
|
36
Edgewise Therapeutics
EWTX
$1.51B
| $3.25M | 0.59% | +100,000 | New | +$3.25M |
|
|
ARYD
37
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $3.14M | 0.57% | +300,000 | New | +$3.14M |
|
|
TCRR
38
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $3.14M | 0.57% | 142,137 -57,730 | -29% | -$1.27M |
|
|
SIEN
39
DELISTED
Sientra, Inc.
SIEN
| $2.76M | 0.5% | +377,900 | New | +$2.76M |
|
40
Dyne Therapeutics
DYN
$1.92B
| $2.71M | 0.49% | +174,360 | New | +$2.71M |
|
41
Revolution Medicines
RVMD
$7.1B
| $2.62M | 0.47% | +57,200 | New | +$2.62M |
|
42
DexCom
DXCM
$29.5B
| $2.49M | 0.45% | 6,935 -1,230 | -15% | -$442K |
|
43
Avidity Biosciences
RNA
$5.99B
| $2.38M | 0.43% | +109,130 | New | +$2.38M |
|
44
Merck
MRK
$210B
| $2.32M | 0.42% | 30,106 +1,700 | +6% | +$131K |
|
|
NARI
45
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $2.3M | 0.41% | +21,450 | New | +$2.3M |
|
46
Astria Therapeutics
ATXS
$349M
| $2.24M | 0.4% | +775,000 | New | +$2.24M |
|
47
NeoGenomics
NEO
$1.13B
| $2.22M | 0.4% | 45,951 | – | – |
|
|
EDAP
48
EDAP TMS
EDAP
$84.5M
| $2.1M | 0.38% | +249,566 | New | +$2.1M |
|
|
RNLX
49
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $2.05M | 0.37% | +80,000 | New | +$2.05M |
|
|
EIGR
50
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.89M | 0.34% | 213,519 +27,800 | +15% | +$246K |
|